Jason Schwartz is an assistant professor in the Department of Health Policy and Management at the Yale School of Public Health. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal.

The bibliographic file:

Dr. Jason Schwartz . (2020). Interview with Dr. Jason Schwartz on processes for determining the safety and efficacy of Covid-19 vaccine candidates and for distributing vaccines.. 2020, de Managing Editor of the Journal Sitio web: https://www.nejm.org/action/showMediaPlayer?doi=10.1056%2FNEJMdo005882&aid=10.1056%2FNEJMp2029479&viewType=Popup&viewClass=Audio&ctype=audiointerview&area=production

CDC to spend $2.1B to bolster US infection control and prevention efforts

Becker’s Hospital Review recently reported on...

La resistencia a los antibióticos en Tanzania es un problema ambiental

Investigadores de la Universidad Estatal de...

Johns Hopkins study shows drones can safely transport large bags of blood

Researchers from Baltimore-based Johns Hopkins...

New treatment for drug-resistant bacterial infections

ScienceDaily has recently reported on a study by...

Ontario scientist thinks old drugs could become our new antibiotics

As the world loses its upper hand in the...

Weak electric currents could help combat superbugs

Medical News Today shared a recent study by...

Cloth skullcaps mitigate OR contamination more effectively than disposable headgear

A study published online by the Journal of the...

Mandatory headwear does not influence surgical site infections

Surgical site infections are noteworthy and...

Transformación de traumas infectados

Cortesía de Mr Hemant K...

Distribuidor exclusivo.

0